Impact on hospitals of price reductions for physician-administered biologics. [PDF]
Health Aff SchRobinson JC +3 more
europepmc +1 more source
Clinical evidence and implementation guidance for biosimilar switching in ankylosing spondylitis. [PDF]
Front PharmacolCai L +6 more
europepmc +1 more source
Peep into anti-vascular endothelial growth factor. [PDF]
Indian J OphthalmolVerma L, Singh S, Ramachandran O.
europepmc +1 more source
Anti-VEGF Therapies in Retinal Disorders: Current Landscape and Future Directions. [PDF]
Clin OphthalmolSheth JU.
europepmc +1 more source
Navigating the Transition: A Scoping Review of System-Level Factors in Biosimilar Integration for Immune-Mediated Inflammatory Diseases. [PDF]
BioDrugsKumar S, Dalbeth N, Gasteiger C.
europepmc +1 more source
Què són els medicaments biosimilars?
Medicaments biosimilars; Medicaments biològics; UtilitzacióMedicamentos biosimilares; Medicamentos biológicos; UtilizaciónBiosimilar medicines; Biological medicines; UseAquest article explica què són els medicaments biosimilars, quins tipus hi ha ...
Grup d'Informació sobre Medicaments Dirigida a la Ciutadania
core
Biologics and biosimilars medication errors in Saudi Arabia: a nationwide retrospective observational real-world study. [PDF]
Front Med (Lausanne)Alshammri NT +3 more
europepmc +1 more source
Comparing the pharmacokinetics of adalimumab originator and biosimilar product in patients with Inflammatory bowel disease or autoimmune disease. [PDF]
Saudi Pharm JDrweesh H +14 more
europepmc +1 more source
Horizon scan of the clinical development landscape of biosimilar products in the UK and EU. [PDF]
Int J Technol Assess Health CareHussain A, Fairbairn R, Khan SK.
europepmc +1 more source
Biosimilars in pemphigus vulgaris
Indian Journal of Dermatology, 2014 Sharmila Patil +3 more
openaire +3 more sources